Literature DB >> 28865519

Pelvic Radiation and Normal Tissue Toxicity.

Sarah Nicholas1, Linda Chen2, Amanda Choflet2, Amanda Fader3, Zachary Guss2, Sarah Hazell2, Daniel Y Song2, Phuoc T Tran2, Akila N Viswanathan2.   

Abstract

Radiation is a component of treatment for many pelvic malignancies, most often originating in the gynecologic, gastrointestinal, and genitourinary systems. Therefore, the management of acute and long-term side effects is an important part of practice as a radiation oncologist, and limiting morbidity is a primary goal. Toxicities vary and are dependent on treatment techniques. Advances in radiation delivery, imaging, and knowledge of underlying biologic determinants of radiation-induced normal tissue toxicity can guide treatment of acute and long-term side effects from pelvic radiation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28865519     DOI: 10.1016/j.semradonc.2017.04.010

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  11 in total

1.  Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins.

Authors:  Sabrina M Bedell; Chloe Hedberg; Anna Griffin; Hannah Pearson; Annelise Wilhite; Nathan Rubin; Britt K Erickson
Journal:  Gynecol Oncol       Date:  2019-06-03       Impact factor: 5.482

Review 2.  Management of Lower Urinary Tract Symptoms after Prostate Radiation.

Authors:  Pansy Uberoi; Charlton A Smith; Alvaro Lucioni
Journal:  Curr Urol Rep       Date:  2021-05-27       Impact factor: 3.092

3.  Effects of Environment and Lifestyle Factors on Anovulatory Disorder.

Authors:  Ying Song; Rong Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Radiotherapy-Specific Chronic Pain Syndromes in the Cancer Population: An Evidence-Based Narrative Review.

Authors:  Jay Karri; Laura Lachman; Alex Hanania; Anuj Marathe; Mani Singh; Nicholas Zacharias; Vwaire Orhurhu; Amitabh Gulati; Alaa Abd-Elsayed
Journal:  Adv Ther       Date:  2021-02-11       Impact factor: 3.845

5.  Prehabilitation for patient positioning: pelvic exercises assist in minimizing inter-fraction sacral slope variability during radiation therapy.

Authors:  Lauren O'Loughlin; Alexander Lukez; Yunsheng Ma; Jennifer Baima; Janaki Moni
Journal:  Med Oncol       Date:  2019-11-12       Impact factor: 3.064

6.  Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies.

Authors:  Shalini Moningi; Ethan B Ludmir; Praveen Polamraju; Tyler Williamson; Marcella M Melkun; Joseph D Herman; Sunil Krishnan; Eugene J Koay; Albert C Koong; Bruce D Minsky; Grace L Smith; Cullen Taniguchi; Prajnan Das; Emma B Holliday
Journal:  Clin Transl Radiat Oncol       Date:  2019-08-27

Review 7.  Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?

Authors:  Joseph D Wilson; Ester M Hammond; Geoff S Higgins; Kristoffer Petersson
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

8.  Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Patients With Stage IIB-IVA Cervical Cancer: A Randomized Phase III Trial.

Authors:  Shasha He; Yan Wang; Yulin Lai; Xinping Cao; Yufeng Ren; Yong Chen
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

9.  Hypoxic Cell-Derived Extracellular Vesicles Aggravate Rectal Injury Following Radiotherapy via MiR-122-5p.

Authors:  Yiqing Xu; Yulong Ge; Xuming Chen; Yingzi Zhang; Huanliang Chen; Dongli Liu; Yue Lu; Yong Liu; Wenzhi Tu
Journal:  Front Cell Dev Biol       Date:  2022-04-26

10.  Development of patient-reported outcomes item set to evaluate acute treatment toxicity to pelvic online magnetic resonance-guided radiotherapy.

Authors:  P K Møller; H Pappot; U Bernchou; T Schytte; K B Dieperink; Pia Krause Møller
Journal:  J Patient Rep Outcomes       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.